tesevatinib
tesevatinib
A member of the class of quinazolines that is quinazoline substituted by (3,4-dichloro-2-fluorophenyl)amino, methoxy, and [(3a<i>R</i>,5<i>r</i>,6a<i>S</i>)-2-methyloctahydrocyclopenta[<em>c</em>]pyrrol-5-yl]methoxy groups at positions 4, 6 and 7, respectively. It is a multi-target tyrosine kinase inhibitor of EGFR, ErbB2, KDR, Flt4 and EphB4 and exhibits anti-cancer properties.